Amy S. Broidrick Qualigen Therapeutics, Inc. (QLGN) insider trading activity

QLGN Quotes by TradingView

Amy S. Broidrick is President/CSO of Qualigen Therapeutics, Inc.. Currently has a direct ownership of 34,500 shares of QLGN, which is worth approximately $5,865. The most recent transaction as insider was on Jun 14, 2022, when has been sold 30,000 shares (Common Stock) at a price of $0.62 per share, resulting in proceeds of $18,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.5K
0% 3M change
0% 12M change
Total Value Held $5,865

AMY S. BROIDRICK Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2022
BUY
Open market or private purchase
$18,600 $0.62 p/Share
30,000 Added 46.51%
34,500 Common Stock
Apr 26 2021
BUY
Open market or private purchase
$9,135 $2.03 p/Share
4,500 Added 50.0%
4,500 Common Stock
ASB

Amy S. Broidrick

President/CSO
Carlsbad, CA

Track Institutional and Insider Activities on QLGN

Follow Qualigen Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells QLGN shares.

Notify only if

Insider Trading

Get notified when an Qualigen Therapeutics, Inc. insider buys or sells QLGN shares.

Notify only if

News

Receive news related to Qualigen Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on QLGN